Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation
Source abstract
Abstract
Suitable colonization and vascularization of tissue-engineered constructs after transplantation represent critical steps for the success of bone repair. Human platelet lysate (hPL) is composed of numerous growth factors known for their proliferative, differentiative and chemo-attractant effects on various cells involved in wound healing and bone growth. The aim of this study was to determine whether the delivery of human mesenchymal stromal cells (hMSC) seeded on hPL-coated hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) scaffolds could enhance vascularization and bone formation, as well as to investigate the mechanisms by which hMSC participate in tissue regeneration. Our study demonstrates that hPL can be coated on HA/β-TCP scaffolds, which play direct and indirect effects on implanted and/or resident stem cells. Effectively, we show that hPL coating directly increases chemo-attraction to and adhesion of hMSC and endothelial cells on the scaffold. Moreover, we show that hPL coating induces hMSC to produce and secrete pro-angiogenic proteins (placental growth factor and vascular endothelial growth factor) which allow the proliferation and specific chemo-attraction of endothelial cells in vitro, thus improving in vivo neovascularization and new bone formation. This study highlights the potential of functionalizing biomaterials with hPL and shows that this growth factor combination can have synergistic effects leading to enhanced bone and blood vessel formation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Periodontal Regeneration and Treatments · Mesenchymal stem cell research · Dental Trauma and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. Tissue engineering10.1126/science.8493529 ↗
2. Enhancement of fracture-healing10.2106/00004623-199506000-00016 ↗
3. Bone regeneration: current concepts and future directions10.1186/1741-7015-9-66 ↗
4. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects10.2106/00004623-199807000-00007 ↗
5. Tissue-engineered bone regeneration10.1038/79449 ↗
6. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones10.1002/(SICI)1097-4636(20000305)49:3<328::AID-JBM5>3.0.CO;2-Q ↗
7. Coquelin L, Fialaire-Legendre A, Roux S, Poignard A, Bierling P, Hernigou P, et al. In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells. Tissue Eng Part A 2012;18(17-18):1921–31.10.1089/ten.tea.2011.0645 ↗
8. Physiological bases of bone regeneration I. Histology and physiology of bone tissue
9. Mechanisms of bone repair and regeneration10.1016/j.molmed.2009.07.002 ↗
10. Angiogenesis and bone repair10.1016/S1359-6446(03)02866-6 ↗
11. Angiogenesis is required for successful bone induction during distraction osteogenesis10.1359/JBMR.050301 ↗
12. Osteogenesis and angiogenesis: the potential for engineering bone10.22203/eCM.v015a08 ↗
13. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization10.1016/j.biomaterials.2008.09.047 ↗
14. Tissue-engineered bone for maxillary sinus augmentation10.1016/j.joms.2004.01.009 ↗
15. Analysis of Ti-6Al-4V implants placed with fibroblast growth factor 1 in rat tibiae
16. Bone defect repair in rat tibia by TGF-beta1 and IGF-1 released from hydrogel scaffold10.1007/s10561-004-0503-7 ↗
17. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration10.1359/JBMR.041226 ↗
18. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation10.1016/j.biomaterials.2009.10.059 ↗
19. Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-210.1016/j.actbio.2009.12.045 ↗
20. Platelet-rich plasmas: growth factor content and roles in wound healing10.1177/154405910508400507 ↗
21. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells10.1089/ten.2006.12.3067 ↗
22. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate10.1016/j.biomaterials.2009.09.043 ↗
23. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro
24. Platelet-rich plasma: growth factor enhancement for bone grafts10.1016/S1079-2104(98)90029-4 ↗
25. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series10.1902/jop.2000.71.10.1654 ↗
26. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: preliminary results10.1053/joms.2002.33107 ↗
27. Maxillary sinus augmentation with anorganic bovine bone (Bio-Oss) and autologous platelet-rich plasma: preliminary clinical and histologic evaluations
28. Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation10.1097/00001665-200503000-00015 ↗
29. Osteogenesis distraction and platelet-rich plasma: combined use in restoration of severe atrophic mandible. Long-term results10.1111/j.1600-0501.2008.01568.x ↗
30. Early experience and results of bone graft enriched with autologous platelet gel for recalcitrant nonunions of lower extremity10.1097/01.ta.0000219937.51190.37 ↗
31. Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect10.1159/000100490 ↗
32. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells10.2106/JBJS.F.01026 ↗
33. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications10.1002/jcp.20391 ↗
34. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts10.1038/sj.bmt.1705798 ↗
35. Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects10.1089/ten.tec.2008.0572 ↗
36. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo10.1182/blood-2008-09-181362 ↗
37. Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integration10.1002/jor.21333 ↗
38. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells
39. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo10.1084/jem.20051772 ↗
40. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro10.1161/01.RES.0000201285.87524.9e ↗
41. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype10.1161/01.ATV.0000222982.55731.f1 ↗
42. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix10.1160/TH06-05-0250 ↗
43. Platelets in regenerative medicine10.1007/s00395-008-0721-4 ↗
44. The role of growth factors in the repair of bone. Biology and clinical applications10.2106/00004623-200206000-00022 ↗
45. Leptin and bone metabolism
46. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast10.1016/j.bbrc.2005.03.210 ↗
47. Mechanisms of angiogenesis10.1134/S0006297908070031 ↗
48. Expression of RANKL/OPG during bone remodeling in vivo10.1016/j.bbrc.2011.07.001 ↗
49. Insulin promotes bone formation in augmented maxillary sinus in diabetic rabbits10.1016/j.ijom.2011.10.004 ↗
50. Basic fibroblast growth factor controls migration in human mesenchymal stem cells10.1634/stemcells.2005-0191 ↗
51. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro10.1016/j.yjmcc.2009.03.011 ↗
52. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors10.1083/jcb.200608093 ↗
53. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury10.1634/stemcells.22-3-415 ↗
54. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-110.1111/j.1749-6632.2001.tb03572.x ↗
55. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells10.1023/B:AGEN.0000021391.88601.92 ↗
56. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie210.1074/jbc.273.29.18514 ↗
57. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts10.1016/S8756-3282(01)00690-1 ↗
58. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released10.1182/blood-2007-09-113837 ↗
59. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model10.1016/j.biomaterials.2009.09.038 ↗
60. The biology of vascular endothelial growth factor10.1210/edrv.18.1.0287 ↗
61. Vascular endothelial growth factor (VEGF) and its receptors10.1096/fasebj.13.1.9 ↗
62. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells10.1093/emboj/18.14.3964 ↗
63. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization10.1016/j.jvs.2009.05.049 ↗
64. The discovery of placenta growth factor and its biological activity10.3858/emm.2012.44.1.025 ↗
65. Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density10.1016/j.exphem.2007.01.051 ↗
66. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue10.1089/ten.tea.2008.0498 ↗
67. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro10.1182/blood.V85.4.929.bloodjournal854929 ↗
68. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro10.1002/jbmr.5650110911 ↗
69. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow10.1210/endo.138.10.5425 ↗